Poseida Therapeutics Inc. (PSTX): Price and Financial Metrics Recent IPO
Poseida Therapeutics Inc. (PSTX) Recent IPO
Today's Latest Price: $11.10 USD
Updated Nov 24 4:00pm
Add PSTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PSTX Stock Price Chart Interactive Chart >
PSTX Price/Volume Stats
| Current price | $11.10 | 52-week high | $17.62 |
| Prev. close | $11.22 | 52-week low | $7.63 |
| Day low | $10.82 | Volume | 64,000 |
| Day high | $11.40 | Avg. volume | 330,202 |
| 50-day MA | $10.28 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 686.20M |
Poseida Therapeutics Inc. (PSTX) Company Bio
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
Loading social stream, please wait...